The House Oversight Committee next week will question Mylan N.V. chief executive Heather Bresch over the dramatic surge in the cost of the auto-injector EpiPen, a hike that drew widespread public ...
The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies' voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products ...
* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...
Sen. Patty Murray (D-WA) on Tuesday sent a letter to Mylan CEO Heather Bresch seeking more details, including e-mail communications, on the ways that Mylan attempted to keep Teva’s generic EpiPen from ...
Mylan beat Sanofi's anti-competitive claims U.S. judge in Kansas weighing dispute June 29 (Reuters) - Drugmaker Sanofi (SASY.PA), opens new tab asked a U.S. judge on Wednesday to curb Mylan's bid to ...
After coming under fire from the public over the increasingly higher prices Mylan was charging for its EpiPen, an emergency epinephrine auto-injector, CEO Heather Bresch was taken to task by lawmakers ...
The pharmaceuticals company Mylan N.V., under pressure for the price surge of its life-saving EpiPen device, has turned to McDermott Will & Emery in the face of mounting criticism from Congress. The ...
Drugmaker Mylan announced on Thursday that it will pay $465 million to settle claims relating to the classification of EpiPen auto-injectors and EpiPen Jr. auto-injectors because of allegations of a ...
June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results